BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer

Abstract

We detected three unknown mutations among 38 patients in a Swiss study of BRCA1/2 mutation patterns. One of these novel mutations is clearly deleterious as it leads to protein truncation at nucleotide 133 of BRCA2.